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Dear Editor,
Concentrations of substances in plasma, in this case CGRP,
can be presented in several different to ways, such as pmol/l
[1–7], pg/ml [8, 9] and just recently as ng/ml [10]. These
different concentrations can be compared when one uses
the molecular weight of 3,790 for CGRP but it takes 5–
10 min of arithmetic to do that. When you normally read a
paper you do not stop and do the arithmetic needed in order
to check the concentrations.
In a recent paper in Journal of Headache and Pain, the
plasma concentration of CGRP in cubital blood is given as
1.03 ng/ml in migraine [10]. This looks apparently reliable,
but when the concentration in pmol/l, the standard way of
presenting CGRP concentrations [1–7], is calculated the
resulting concentration is 272 pmol/l. This was in migraine
patients in the cubital vein outside attacks [10] and the
CGRP levels are higher than any CGRP levels reported
before both in external jugular blood [1–5], and cubital
blood [6–9]. The authors state that the analyses were done
with a commercially available ELISA kit and that the kit
had a good sensitivity (range 0–25 ng/ml), but the detec-
tion limit for CGRP is not stated.
The best way to avoid such problems is to present CGRP
levels in pmol/l. One can then easily skim the literature and
compare results in different studies.
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